Two National Guard members shot near White House
Cathie Wood’s ARK ETF published their daily trades for Wednesday, November 26, 2025, showcasing significant moves in technology and innovation sectors. The largest trade of the day was the sale of 27,102 shares of Tesla Inc (NASDAQ:TSLA) through the ARKK ETF, amounting to $11,366,578. This follows a trend of divestment in Tesla shares, as ARK has been reducing its holdings in the company over recent days.
On the buying side, ARK made a substantial purchase of Coinbase Global Inc (NASDAQ:COIN), acquiring a total of 62,166 shares across its ARKK, ARKW, and ARKF ETFs, for a total of $15,797,623. This marks a continuation of ARK’s increasing investment in the cryptocurrency exchange, following significant buys in previous sessions.
Another notable purchase was in Deere & Co (NYSE:DE), with ARK acquiring 30,518 shares through its ARKK, ARKQ, and ARKX ETFs, totaling $15,201,931. This move highlights ARK’s interest in companies at the intersection of technology and traditional industries.
ARK also increased its position in CoreWeave Inc (CRWV) by purchasing 10,308 shares through its ARKK ETF, valued at $734,857, and made smaller acquisitions in CRISPR Therapeutics AG (NASDAQ:CRSP), Klarna Group PLC (KLAR), and Recursion Pharmaceuticals Inc (NASDAQ:RXRX).
On the selling side, ARK offloaded shares in several companies. Notable sales include 13,071 shares of Exact Sciences Corp (NASDAQ:EXAS) for $1,321,870, and 98,492 shares of Ibotta Inc (IBTA) for $2,260,391, continuing a trend of reducing its stake in these companies. Additionally, ARK sold 85,356 shares of Iridium Communications Inc (NASDAQ:IRDM) for $1,404,106 and 19,672 shares of GitLab Inc (NASDAQ:GTLB) for $811,273.
These trades reflect ARK’s strategic shifts in its portfolio, focusing on enhancing positions in high-growth technology and innovation sectors while trimming investments in other areas. Investors may want to keep an eye on these trends as they develop.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
